FDA Inspection 944107 — Octapharma Plasma, Inc.

Octapharma Plasma, Inc. — FEI 3006188513

The FDA completed an inspection of Octapharma Plasma, Inc. on September 14, 2015 in Springfield, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 14, 2015
Fiscal Year
2015
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Springfield, IL (United States)